Want to see KR:228760 full AI Analyst Report?
Genomictree, Inc. (228760) Income Statement
Genomictree, Inc. Income Statement
Last quarter (Q1 2026), Genomictree, Inc.'s total revenue was $381.61M, an increase of 20.58% from the same quarter last year. In Q1, Genomictree, Inc.'s net income was $-1.95B. See Genomictree, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 3.76B | $ 2.36B | $ 3.42B | $ 29.87B | $ 5.14B | |
| $ 73.36M | $ -726.56M | $ -270.02M | $ 24.99B | $ 2.52B | |
| $ 11.37B | $ 14.59B | $ 17.03B | $ 22.59B | $ 12.37B | |
| Depreciation and Amortization | $ 1.02B | $ 1.20B | $ 1.18B | $ 1.34B | $ 1.02B |
| $ -10.28B | $ -8.90B | $ -6.27B | $ 3.02B | $ -5.80B | |
| $ -11.30B | $ -15.31B | $ -17.30B | $ 8.90B | $ -9.86B | |
| $ 2.18B | $ 4.92B | $ 7.80B | $ -6.10B | $ -1.57B | |
| $ -9.11B | $ -10.39B | $ -9.50B | $ -3.69B | $ -11.42B | |
| $ -8.99B | $ -10.24B | $ -8.76B | $ -6.24B | $ -11.42B | |
| Per Share Metrics | |||||
| Basic EPS | $ -374.27 | $ -432.48 | $ -402.32 | $ -297.25 | $ -553.00 |
| Diluted EPS | $ -374.27 | $ -432.48 | $ -402.32 | $ -297.25 | $ -553.00 |
| Weighted Average Shares Outstanding | 24.01M | 23.68M | 21.76M | 20.98M | 20.66M |
| Weighted Average Shares Outstanding (Diluted) | 24.01M | 23.68M | 21.76M | 20.98M | 20.66M |
Currency in KRW
